Compare SCYX & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCYX | DAIO |
|---|---|---|
| Founded | 1999 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.0M | 29.7M |
| IPO Year | 2014 | 2026 |
| Metric | SCYX | DAIO |
|---|---|---|
| Price | $5.14 | $3.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $5.22 |
| AVG Volume (30 Days) | ★ 239.4K | 44.2K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $257,000.00 | ★ $21,500,000.00 |
| Revenue This Year | N/A | $4.51 |
| Revenue Next Year | $608.78 | $30.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.57 | $2.16 |
| 52 Week High | $5.62 | $4.49 |
| Indicator | SCYX | DAIO |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 51.20 |
| Support Level | $0.65 | $3.03 |
| Resistance Level | $5.58 | $3.29 |
| Average True Range (ATR) | 0.44 | 0.22 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 85.57 | 77.08 |
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
Data I/O Corp provides semiconductor programming, security provisioning, and intellectual property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It operates as a single segment entity, with the sole objective to design, manufacture, and sell programming solutions and Programming-as-a-Service (PaaS) to the world's various electronics manufacturers including OEMs, CMs and EMS companies. The company operate in three separate locations Redmond, Washington; Shanghai, China; and Munich, Germany.